Thomas Robert Jahn (Thomas R Jahn)

Years Active: 2017-2017
Publications (10 Years): 3

AbbVie Deutschland GmbH and Co KG Ludwigshafen

University of Leeds (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Deutschland GmbH and Co KG Ludwigshafen

Germany

Lab Head :: Neuroscience Discovery

University of Heidelberg & DKFZ

Germany

Group Leader :: Proteostasis in Neurodegenerative Disease

University of Cambridge

United Kingdom

Wellcome Trust Postdoctoral Fellow :: Chemistry & Genetics

Education History

University of Leeds

United Kingdom

PHD :: Structural Biology

Publications

Nina M Dräger, Eliana Nachman, Moritz Winterhoff, Stefan Brühmann, Pranav Shah, Taxiarchis Katsinelos, Steeve Boulant, Aurelio A Teleman, Jan Faix, Thomas Robert Jahn
Bin1 directly remodels actin dynamics through its BAR domain. EMBO reports 18 (11) (2017)
Ramona F Sowade, Thomas Robert Jahn
Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo. Nature communications 8 (1) (2017)
Jiaxing Li, Yao V Zhang, Elham Asghari Adib, Doychin T Stanchev, Xin Xiong, Susan Klinedinst, Pushpanjali Soppina, Thomas Robert Jahn, Richard I Hume, Tobias M Rasse, Catherine A Collins
Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104. eLife 6 (2017)

Thomas Robert Jahn.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas R Jahn)